Globally, non-steroidal anti-inflammatory drugs (NSAIDs) are highly used to treat pain. With the rise of the COVID-19 pandemic, the safety of NSAIDs use has been called into question. These concerns are worthy of review. At present, there is no compelling data showing that NSAIDs worsen the severity of COVID-19 symptoms or increase one's likelihood of contracting the illness. For patients in pain and without symptoms that could potentially be attributed to COVID-19 (cough, fevers/chills, lethargy, myalgias, anosmia and so on), NSAIDs should continue to remain a viable option to provide analgesia to patients in need.
Recommended CitationHerzberg, Daniel L; Sukumaran, Harry P; and Viscusi, Eugene R., "NSAIDs for analgesia in the era of COVID-19" (2020). Department of Anesthesiology Faculty Papers. Paper 64.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License